Inventor · disambiguated record
Yosuke Takanashi
Also filed as: TAKANASHI YOSUKE
10 granted patents·12 pending applications·45 citations·filing 2012–2023
86Inventor score
Files withSUMITOMO DAINIPPON PHARMA CO LTD10SUMITOMO PHARMA CO LTD6BOSTON BIOMEDICAL INC4DAINIPPON SUMITOMO PHARMA CO1SHIRO TOMOYA1
Top patents by PatentIndex Score
22 records- 0193US9248173B2WT1 antigen peptide conjugate vaccineSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2015·Granted Feb 2, 2016·14 cites·28 claims
- 0292US9181302B2WT1 antigen peptide conjugate vaccineSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2014·Granted Nov 10, 2015·17 cites·21 claims
- 0388US11759509B2WT1 antigen peptide conjugate vaccineSUMITOMO PHARMA CO LTD·Filed 2018·Granted Sep 19, 2023·2 cites·13 claims
- 0483US11795195B2Antibody-drug conjugates including hemiasterlin derivativeSUMITOMO PHARMA CO LTD·Filed 2018·Granted Oct 24, 2023·2 cites·24 claims
- 0573US10588952B2Conjugate vaccine using trimming function of ERAP1SUMITOMO DAINIPPON PHARMA CO LTD·Filed 2014·Granted Mar 17, 2020·2 cites·8 claims
- 0673US9040516B2Uracil derivative and use thereof for medical purposesSHIRO TOMOYA·Filed 2012·Granted May 26, 2015·7 cites·20 claims
- 0772US9227962B2Heterocyclic substituted-3-heteroarylidenyl-2-indolinone derivativeDAINIPPON SUMITOMO PHARMA CO·Filed 2014·Granted Jan 5, 2016·1 cites·18 claims
- 0872US2024059732A1Antibody-Drug Conjugates Including Hemiasterlin DerivativeSUMITOMO PHARMA CO LTD·Filed 2023·Application pending·0 cites
- 0959US2019241550A1Heterocyclic substituted-3-heteroarylidenyl-2-indolinone derivativeBOSTON BIOMEDICAL INC·Filed 2018·Application pending·0 cites
- 1058US2020171136A1Conjugate vaccine using trimming function of erap1SUMITOMO DAINIPPON PHARMA CO LTD·Filed 2020·Application pending·0 cites
- 1153US2016114019A1Wt1 antigen peptide conjugate vaccineSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2015·Application pending·0 cites
- 1251US2016075697A1Heterocyclic substituted-3-heteroarylidenyl-2-indolinone derivativeBOSTON BIOMEDICAL INC·Filed 2015·Application pending·0 cites
- 1350US2020368338A1Conjugate of wt1-derived peptides and composition comprising the sameSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2018·Application pending·0 cites
- 1449US2023287027A1Adjuvant with tlr4 agonist activitySUMITOMO PHARMA CO LTD·Filed 2021·Application pending·0 cites
- 1548US2016031888A13-(aryl or heteroaryl) methyleneindolin-2-one derivatives as inhibitors of cancer stem cell pathway kinases for the treatment of cancerBOSTON BIOMEDICAL INC·Filed 2014·Application pending·0 cites
- 1647US2019241569A13-(aryl or heteroaryl) methyleneindolin-2-one derivatives as inhibitors of cancer stem cell pathway kinases for the treatment of cancerBOSTON BIOMEDICAL INC·Filed 2018·Application pending·0 cites
- 1747US2020207782A1Chemically activated water-soluble prodrugSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2018·Application pending·0 cites
- 1847US2021100886A1Wt1 cancer antigen peptides and peptide conjugates comprising the peptidesSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2018·Application pending·0 cites
- 1946US12383608B2WT1 helper peptides and combinations of WT1 helper peptide and conjugate of cancer antigen peptidesSUMITOMO PHARMA CO LTD·Filed 2017·Granted Aug 12, 2025·0 cites·27 claims
- 2042US12427192B2Water soluble adjuvant and composition containing sameSUMITOMO PHARMA CO LTD·Filed 2020·Granted Sep 30, 2025·0 cites·39 claims
- 2142US2022241409A1Water soluble adjuvant and composition containing sameSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2020·Application pending·0 cites
- 2234US10294237B2Bicyclic heterocyclic amide derivativeSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2016·Granted May 21, 2019·0 cites·36 claims
Join the waitlist — get patent alerts
Get an alert when Yosuke Takanashi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →